Amalgamated Bank Sells 5,953 Shares of Agilent Technologies, Inc. (NYSE:A)

Amalgamated Bank decreased its position in Agilent Technologies, Inc. (NYSE:A) by 9.7% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 55,107 shares of the medical research company’s stock after selling 5,953 shares during the period. Amalgamated Bank’s holdings in Agilent Technologies were worth $7,403,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the company. IFP Advisors Inc increased its position in Agilent Technologies by 17.7% during the 4th quarter. IFP Advisors Inc now owns 458 shares of the medical research company’s stock valued at $62,000 after purchasing an additional 69 shares during the period. Brown Brothers Harriman & Co. boosted its stake in shares of Agilent Technologies by 13.5% during the third quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company’s stock valued at $96,000 after purchasing an additional 77 shares in the last quarter. Rothschild Investment LLC boosted its stake in shares of Agilent Technologies by 19.2% during the fourth quarter. Rothschild Investment LLC now owns 491 shares of the medical research company’s stock valued at $66,000 after purchasing an additional 79 shares in the last quarter. Rovin Capital UT ADV increased its holdings in Agilent Technologies by 1.6% during the third quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company’s stock valued at $750,000 after buying an additional 81 shares during the period. Finally, Integrated Advisors Network LLC raised its stake in Agilent Technologies by 2.5% in the third quarter. Integrated Advisors Network LLC now owns 3,582 shares of the medical research company’s stock worth $532,000 after buying an additional 86 shares in the last quarter.

Analyst Ratings Changes

A has been the topic of a number of analyst reports. Bank of America cut their price target on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a report on Friday, December 13th. Barclays upgraded Agilent Technologies from an “underweight” rating to an “equal weight” rating and lifted their target price for the company from $135.00 to $145.00 in a research note on Monday, February 10th. Citigroup boosted their target price on shares of Agilent Technologies to $165.00 and gave the stock a “buy” rating in a report on Thursday, December 19th. JPMorgan Chase & Co. lowered their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, November 26th. Finally, Sanford C. Bernstein reduced their price objective on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research note on Tuesday, November 26th. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $144.38.

Agilent Technologies Trading Up 0.2 %

Shares of Agilent Technologies stock opened at $134.51 on Thursday. The firm’s 50 day simple moving average is $140.90 and its two-hundred day simple moving average is $139.28. The firm has a market capitalization of $38.37 billion, a price-to-earnings ratio of 30.43, a PEG ratio of 3.66 and a beta of 1.07. Agilent Technologies, Inc. has a 12-month low of $124.16 and a 12-month high of $155.35. The company has a current ratio of 2.09, a quick ratio of 1.58 and a debt-to-equity ratio of 0.57.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.04. The firm had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. Analysts predict that Agilent Technologies, Inc. will post 5.56 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.74%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio (DPR) is 22.40%.

Insider Activity at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares of the company’s stock, valued at $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.